Back to search
Cardiovascular Risk Markers
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cardiovascular Risk Markers trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cardiovascular Risk Markers trials you may qualify forIn a single-blind, randomised, placebo-controlled crossover manner, this study aims to assess the impact of a high-fat mixed meal containing a whey protein (WP)…
The primary purpose of this study is to determine if there are significant differences with respect to baseline between those randomized to CGo and standard-of-…
Background: Heart disease is a leading cause of death in the United States. Healthy diet and exercise improve heart health. Some features of where a person liv…
Patients with coronary heart disease who take dual antiplatelet therapy face two serious risks: thrombosis and major bleeding. This study aims to develop better…
Background: People with systemic lupus erythematosus (SLE) are at risk of developing complications in their blood vessels. This can increase the risk of heart…
A person who has experienced a cardiac arrest with no apparent cause is at risk of having recurrent cardiac arrest. Hence an implantable cardioverter-defibrilla…
Although advances in treatment and patient management have considerably improved post-infarction prognosis, the risk of sudden cardiac death remains a major con…
The purpose of this study is to learn more about the effects of abdominal compression and the medication midodrine, two interventions used for the treatment of…